Determination of glyoxal and methylglyoxal in serum by UHPLC coupled with fluorescence detection
Determination of glyoxal and methylglyoxal in serum by UHPLC coupled with fluorescence detection
复制标题
DOI:
10.1016/j.ab.2019.02.014
复制
发表时间:
2019-05-15
影响因子:
2.9
通讯作者:
Muncha, Gerald
中科院分区:
文献类型:
--
作者:
Dhananjayan, Karthik;Irrgang, Felix;Muncha, Gerald
Glyoxal (GO) and methylglyoxal (MGO) are two important biomarkers in diabetes. Analytical methods for determination of GO and MGO in serum samples are either HPLC with UV-Vis (low sensitivity) or MS/MS (expensive) detection. These disadvantages have hampered the introduction of these biomarkers as a routine analyte for diabetes diagnostics into the clinical laboratory. In this study, we introduce a UHPLC method with fluorescence detection for the measurement of GO and MGO in serum samples by pre-column derivatization at neutral pH with 5, 6-diamino-2,4-dihydroxypyrimidine sulfate (DDP) to form lumazines. The method was validated as per FDA guidelines. Using this method, we have determined GO and MGO in a variety of animal serum samples, and for example, determined the GO and MGO concentration in adult bovine serum to be 852 +/- 27 and 192 +/- 10 nmol/L, respectively. In human serum, GO and MGO levels in non-diabetic subjects (n = 14) were determined to be 154 +/- 88 and 98 +/- 27 nmol/L, and in serum samples from subjects with diabetes (n = 14) 244 +/- 137 and 190 +/- 68 nmol/L, respectively. In addition, interference studies showed that physiological serum components did not lead to an artificial increase in the levels of GO and MGO.